MedTrace Logo

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

NCT00512811 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2007-08-08

No results posted yet for this study

Summary

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Conditions

  • Bronchiolitis

Interventions

DRUG

furosemide

Sponsors & Collaborators

  • Baqiyatallah Medical Sciences University

    lead OTHER

Principal Investigators

  • Mostafa Ghanei, MD · Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
32 Years
Max Age
83 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00512811 on ClinicalTrials.gov